Atossa Therapeutics, Inc.

Filed a patent for "endoxifen compositions and methods of use thereof and synthesis thereof" on Wed, July 19, 2023

Filed a patent for "anti-tumor compounds and methods of use thereof and synthesis thereof" on Wed, July 19, 2023

Filed a patent for "keto acid biopolymers and uses thereof" on Tue, January 3, 2023

Filed a patent for "bacterial compositions for metabolizing uremic toxins" on Thu, June 8, 2023

Filed a patent for "keto acid biopolymers and polyol keto esters and uses thereof" on Fri, June 23, 2023

Filed a patent for "methods for making and using endoxifen" on Thu, October 3, 2024

Filed a patent for "heparin and n-acetylcysteine for the treatment of lung injury" on Thu, April 13, 2023

Filed a patent for "methods for making and using endoxifen" on Thu, June 15, 2023

Filed a patent for "high dose endoxifen formulations and methods of use" on Wed, January 4, 2023

Filed a patent for "methods of enriching (z)-endoxifen" on Wed, January 4, 2023

Filed a patent for "methods for making and using endoxifen" on Thu, November 16, 2023

Filed a patent for "viral vaccine compositions for inoculating a subject against a coronavirus, an influenza virus, or both" on Thu, November 16, 2023

Filed a patent for "topical compositions and methods for treatment" on Thu, May 9, 2024

Filed a patent for "endoxifen for treatment of ovarian cancer" on Thu, May 16, 2024

Filed a patent for "high dose endoxifen formulations and methods of use" on Tue, April 26, 2022

Filed a patent for "methods of treating or preventing a viral infection using bacteriophages" on Thu, February 23, 2023

Filed a patent for "heparin compositions for treatment of lung damage and methods of use thereof" on Thu, July 28, 2022